[ Price : $8.95]
FDA warns New York, NY-based Allovate Therapeutics that it is illegally marketing its Allerdent toothpaste that is an unapproved n...[ Price : $8.95]
FDA warns Nesconset, NY-based LifeVac that it is illegally marketing and distributing an airway clearance device.[ Price : $8.95]
FDA accepts for review a Cingulate NDA for CTx-1301 (dexmethylphenidate), a once-daily stimulant designed to treat attention-defic...[ Price : $8.95]
An Astellas Phase 2 study evaluating zolbetuximab in combination with standard chemotherapy for metastatic pancreatic cancer fails...[ Price : $8.95]
FDA publishes a guidance with recommendations for submitting clinical trial data sets for response assessments for treatments of a...[ Price : $8.95]
Pfizer says its Tukysa met the progression-free survival endpoint in the HER2CLIMB-05 breast cancer trial combining Tukysa with st...[ Price : $8.95]
FDA accepts for review a Rocket Pharmaceuticals BLA resubmission for Kresladi (marnetegragene autotemcel), a gene therapy for seve...[ Price : $8.95]
FDA approves an expanded indication for Teva and Medincells Uzedy (risperidone) to permit its use as monotherapy or adjunctive the...